NR 508 Final Exam Week 8 Final Exam NR 508 ADVANCED PHARMACOLOGY.

NR 508 Final Exam/ Week 8 Final Exam NR 508: ADVANCED PHARMACOLOGY
(Complete solutions and resources for the course
exam)
NR 508 Final Exam

Question 1
pts
A patient who has diabetes reports intense discomfort when needing to void.
A urinalysis is normal. To treat this, the primary care NP should consider
prescribing:

flavoxate (Urispas).


bethanechol (Urecholine).


phenazopyridine (Pyridium).

Correct!

oxybutynin chloride (Ditropan XL).

This patient is describing urge incontinence, or overactive bladder, which
occurs when the detrusor muscle is hyperactive, causing an intense urge to
void before the bladder is full. Urge incontinence is associated with many
conditions, including diabetes. Oxybutynin chloride, which is an
anticholinergic, acts to decrease detrusor overactivity and is indicated for
treatment of urge incontinence. Flavoxate is used to treat dysuria associated
with UTI. Bethanechol is indicated for urinary retention. Phenazopyridine is
used to treat dysuria.

Question 2
pts
A patient reports difficulty returning to sleep after getting up to go to the
bathroom every night. A physical examination and a sleep hygiene history
are noncontributory. The primary care NP should prescribe:

zaleplon.

Correct!

NR 508